Skip to content

Drug interactions

Ifosfamide + Thiotepa

Severity: Major

Ifosfamide and Thiotepa: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both agents are alkylating drugs that cause myelosuppression. Thiotepa is also metabolised by CYP3A4 and CYP2B6, so the two drugs may compete for metabolism and alter exposure to active metabolites. Overlapping toxicities include profound cytopenias and neurotoxicity.

What this interaction means in plain words

Ifosfamide and Thiotepa can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Ifosfamide belongs to Oncology; Thiotepa belongs to Oncology.

Evidence level: Moderate

Why it happens

Additive myelosuppression and organ toxicity, with possible competition for CYP2B6/3A4 metabolism.

What to do

Monitor blood counts and neurological and renal status closely, and follow protocol dose reductions in high-dose regimens. Provide supportive care for cytopenias.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ifosfamide and Thiotepa, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ifosfamide with Thiotepa?

MediHelp rates the interaction as major. Ifosfamide and Thiotepa can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both agents are alkylating drugs that cause myelosuppression. Thiotepa is also metabolised by CYP3A4 and CYP2B6, so the two drugs may compete for metabolism and alter exposure to active metabolites. Overlapping toxicities include profound cytopenias and neurotoxicity.

How serious is the interaction between Ifosfamide and Thiotepa?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and neurological and renal status closely, and follow protocol dose reductions in high-dose regimens. Provide supportive care for cytopenias.

What other medicines interact with Ifosfamide?

MediHelp also lists interactions of Ifosfamide with, for example, Adenovirus types 4 and 7 live, Measles mumps and rubella vaccine, Measles mumps and rubella vaccine live. The full list is on the Ifosfamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in